Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Bausch Health Companies Inc (NYSE: BHC) closed at $6.82 in the last session, down -1.59% from day before closing price of $6.93. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 1.85 million shares were traded. BHC stock price reached its highest trading level at $7.02 during the session, while it also had its lowest trading level at $6.81.
Ratios:
We take a closer look at BHC’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.89 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.42. For the most recent quarter (mrq), Quick Ratio is recorded 0.97 and its Current Ratio is at 1.30.
Upgrades & Downgrades
In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.
On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.
Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’25 when PAULSON & CO. INC. bought 2,500,000 shares for $6.25 per share. The transaction valued at 15,625,000 led to the insider holds 73,255,869 shares of the business.
Carson Seana sold 13,370 shares of BHC for $97,735 on Sep 08 ’25. The EVP, General Counsel now owns 499,585 shares after completing the transaction at $7.31 per share. On Sep 08 ’25, another insider, Carson Seana, who serves as the Officer of the company, bought 13,370 shares for $7.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2529877248 and an Enterprise Value of 23222681600. As of this moment, Bausch’s Price-to-Earnings (P/E) ratio for their current fiscal year is 7.04, and their Forward P/E ratio for the next fiscal year is 1.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 2.316 whereas that against EBITDA is 7.067.
Stock Price History:
The Beta on a monthly basis for BHC is 0.37, which has changed by -0.16706729 over the last 52 weeks, in comparison to a change of 0.13844287 over the same period for the S&P500. Over the past 52 weeks, BHC has reached a high of $8.69, while it has fallen to a 52-week low of $4.25. The 50-Day Moving Average of the stock is 5.84%, while the 200-Day Moving Average is calculated to be 9.17%.
Shares Statistics:
According to the various share statistics, BHC traded on average about 2.33M shares per day over the past 3-months and 3636860 shares per day over the past 10 days. A total of 370.47M shares are outstanding, with a floating share count of 328.20M. Insiders hold about 11.42% of the company’s shares, while institutions hold 66.57% stake in the company. Shares short for BHC as of 1763078400 were 6659022 with a Short Ratio of 2.86, compared to 1760486400 on 7464358. Therefore, it implies a Short% of Shares Outstanding of 6659022 and a Short% of Float of 1.94.
Earnings Estimates
At present, 5.0 analysts are actively evaluating the performance of Bausch Health Companies Inc (BHC) in the stock market.The consensus estimate for the next quarter is $0.77, with high estimates of $0.84 and low estimates of $0.65.
Analysts are recommending an EPS of between $4.01 and $3.72 for the fiscal current year, implying an average EPS of $3.89. EPS for the following year is $4.16, with 5.0 analysts recommending between $4.66 and $3.72.
Revenue Estimates
According to 6 analysts,. The current quarter’s revenue is expected to be $2.72B. It ranges from a high estimate of $2.76B to a low estimate of $2.68B. As of. The current estimate, Bausch Health Companies Inc’s year-ago sales were $2.56BFor the next quarter, 6 analysts are estimating revenue of $2.42B. There is a high estimate of $2.43B for the next quarter, whereas the lowest estimate is $2.41B.
A total of 6 analysts have provided revenue estimates for BHC’s current fiscal year. The highest revenue estimate was $10.23B, while the lowest revenue estimate was $10.15B, resulting in an average revenue estimate of $10.18B. In the same quarter a year ago, actual revenue was $9.62BBased on 6 analysts’ estimates, the company’s revenue will be $10.52B in the next fiscal year. The high estimate is $10.77B and the low estimate is $10.08B.
